Oregon

Oregon

  • Epic e-prescribing returns to normal operations following cyber-attack

    Epic e-prescribing returns to normal operations following cyber-attack

    Please revert to normal e-prescribing workflows and stop using paper prescriptions.

    Read Article
  • Dose-escalation studies aspire to fill gaps in cancer treatment options

    Dose-escalation studies aspire to fill gaps in cancer treatment options

    Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

    Read Article
  • FDA approves cellular therapy, offering hope to more people with cancer

    FDA approves cellular therapy, offering hope to more people with cancer

    The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

    Read Article
  • Gateway Food Pantry provides meals and hope to those in need

    Gateway Food Pantry provides meals and hope to those in need

    Supporting thousands of patients experiencing food insecurity, a converted space at Providence Gateway Internal Medicine clinic is filled with fresh fruits and vegetables, meat, milk, eggs and more.

    Read Article
  • Providence oncology nurse practitioner receives Values in Action Award

    Providence oncology nurse practitioner receives Values in Action Award

    Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.

    Read Article
  • GET THE APP ›
  • Celebrating Women in Science

    Celebrating Women in Science

    In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.

    Read Article
  • Virtual education: Food and common cancer myths

    Virtual education: Food and common cancer myths

    Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

    Read Article
  • Studies address need for more treatment options in endometrial cancer and AML

    Studies address need for more treatment options in endometrial cancer and AML

    New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy

    Read Article
  • FIND A DOCTOR ›
  • Providence and Regence Reach Agreement

    Providence and Regence Reach Agreement

    Providence and Regence have reached an agreement to continue care delivery services together.

    Read Article
  • Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy

    Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy

    "Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.

    Read Article
  • Promising results of amivantamab studies appear in high-profile journals

    Promising results of amivantamab studies appear in high-profile journals

    New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

    Read Article
  • CORE selected to create an evaluation design for Oregon's 2022-2027 Medicaid waiver

    CORE selected to create an evaluation design for Oregon's 2022-2027 Medicaid waiver

    The Oregon Health Authority has selected the Portland, Oregon-based Center for Outcomes Research & Education (CORE) to create an evaluation design for Oregon's 2022-2027 1115 Medicaid waiver.

    Read Article
  • LEARN MORE
  • A remarkable year of engagement and advancements at Providence Cancer Institute

    A remarkable year of engagement and advancements at Providence Cancer Institute

    Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.

    Read Article
  • Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop

    Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop

    Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.

    Read Article
  • FIND A CLINIC ›
  • Immunotherapies for GI and lung cancers evaluated in new studies

    Immunotherapies for GI and lung cancers evaluated in new studies

    A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

    Read Article
  • Genomic testing can improve outcomes for people with advanced cancer, study shows

    Genomic testing can improve outcomes for people with advanced cancer, study shows

    Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

    Read Article
  • Providence researchers contribute to 21 studies at SITC2023

    Providence researchers contribute to 21 studies at SITC2023

    SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.

    Read Article
  • Watch a free virtual talk on lung cancer prevention and treatment

    Watch a free virtual talk on lung cancer prevention and treatment

    Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.

    Read Article
  • Providence Oregon Hospice fulfills a patient’s dying wish

    Providence Oregon Hospice fulfills a patient’s dying wish

    It took a total team effort to make a hospice patient’s dream come true of touching a horse before she died.

    Read Article
  • New studies address unmet needs in treating triple-negative breast cancer

    New studies address unmet needs in treating triple-negative breast cancer

    Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

    Read Article
  • loading
    Loading More...